Motif ID: Foxa2_Foxa1
Z-value: 1.871


Transcription factors associated with Foxa2_Foxa1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Foxa1 | ENSMUSG00000035451.6 | Foxa1 |
Foxa2 | ENSMUSG00000037025.5 | Foxa2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxa1 | mm10_v2_chr12_-_57546121_57546141 | 0.24 | 2.3e-01 | Click! |
Foxa2 | mm10_v2_chr2_-_148046896_148046991 | 0.12 | 5.8e-01 | Click! |
Top targets:
Showing 1 to 20 of 200 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 141 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 17.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.9 | 13.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
4.2 | 12.6 | GO:0021759 | globus pallidus development(GO:0021759) |
3.2 | 12.6 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.1 | 12.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.0 | 10.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 10.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.9 | 9.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
2.2 | 8.9 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.7 | 8.0 | GO:0060539 | diaphragm development(GO:0060539) |
2.5 | 7.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.4 | 7.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.1 | 6.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.6 | 6.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.7 | 6.4 | GO:0090399 | replicative senescence(GO:0090399) |
0.6 | 6.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 6.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 6.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 5.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
1.1 | 5.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 69 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 13.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 10.7 | GO:0030426 | growth cone(GO:0030426) |
2.6 | 10.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 10.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 10.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 8.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.7 | 7.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 6.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.9 | 5.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 5.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.7 | 5.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.6 | 5.0 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 4.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 4.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.5 | 3.8 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 3.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 3.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 3.0 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 3.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 2.7 | GO:0001772 | immunological synapse(GO:0001772) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 102 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 38.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.4 | 18.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.3 | 15.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 12.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
2.0 | 11.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 10.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 8.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
1.5 | 7.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 7.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.3 | 6.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 5.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 5.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 5.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 5.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.5 | 5.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.5 | 4.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 4.1 | GO:0051015 | actin filament binding(GO:0051015) |
1.0 | 4.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 3.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 3.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |